Publications by authors named "Paul Haluska"

71Publications

Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).

Authors:
Aline Talhouk Joshy George Chen Wang Timothy Budden Tuan Zea Tan Derek S Chiu Stefan Kommoss Huei San Leong Stephanie Chen Maria P Intermaggio Blake Gilks Tayyebeh M Nazeran Mila Volchek Wafaa Elatre Rex C Bentley Janine Senz Amy Lum Veronica Chow Hanwei Sudderuddin Robertson Mackenzie Samuel C Y Leong Geyi Liu Dustin Johnson Billy Chen Aocs Group Jennifer Alsop Susana N Banerjee Sabine Behrens Clara Bodelon Alison H Brand Louise Brinton Michael E Carney Yoke-Eng Chiew Kara L Cushing-Haugen Cezary Cybulski Darren Ennis Sian Fereday Renée T Fortner Jesús García-Donas Aleksandra Gentry-Maharaj Rosalind Glasspool Teodora Goranova Casey S Greene Paul Haluska Holly R Harris Joy Hendley Brenda Y Hernandez Esther Herpel Mercedes Jimenez-Linan Chloe Karpinskyj Scott H Kaufmann Gary L Keeney Catherine J Kennedy Martin Köbel Jennifer M Koziak Melissa C Larson Jenny Lester Liz-Anne Lewsley Jolanta Lissowska Jan Lubiński Hugh Luk Geoff Macintyre Sven Mahner Iain A McNeish Janusz Menkiszak Nikilyn Nevins Ana Osorio Oleg Oszurek José Palacios Samantha Hinsley Celeste L Pearce Malcolm C Pike Anna M Piskorz Isabelle Ray-Coquard Valerie Rhenius Cristina Rodriguez-Antona Raghwa Sharma Mark E Sherman Dilrini De Silva Naveena Singh Peter Sinn Dennis Slamon Honglin Song Helen Steed Euan A Stronach Pamela J Thompson Aleksandra Tołoczko Britton Trabert Nadia Traficante Chiu-Chen Tseng Martin Widschwendter Lynne R Wilkens Stacey J Winham Boris Winterhoff Alicia Beeghly-Fadiel Javier Benitez Andrew Berchuck James D Brenton Robert Brown Jenny Chang-Claude Georgia Chenevix-Trench Anna deFazio Peter A Fasching María J García Simon A Gayther Marc T Goodman Jacek Gronwald Michelle J Henderson Beth Y Karlan Linda E Kelemen Usha Menon Sandra Orsulic Paul D P Pharoah Nicolas Wentzensen Anna H Wu Joellen M Schildkraut Mary Anne Rossing Gottfried E Konecny David G Huntsman Ruby Yun-Ju Huang Ellen L Goode Susan J Ramus Jennifer A Doherty David D Bowtell Michael S Anglesio

Clin Cancer Res 2020 Oct 17;26(20):5411-5423. Epub 2020 Jun 17.

British Columbia's Gynecological Cancer Research Program (OVCARE), BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-20-0103DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572656PMC
October 2020

High expression of orphan nuclear receptor NR4A1 in a subset of ovarian tumors with worse outcome.

Gynecol Oncol 2016 05 11;141(2):348-356. Epub 2016 Mar 11.

Department of Pharmacology and Chemical Biology, Womens Cancer Research Center, Magee-Womens Research Institute, and University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2016.02.030DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154956PMC
May 2016

Molecular and clinical implementations of ovarian cancer mouse avatar models.

Chin Clin Oncol 2015 Sep;4(3):30

Division of Medical Oncology, Mayo Clinic College of Medicine, 200 First St. SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2304-3865.2015.04.01DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750944PMC
September 2015

Understanding the Key to Targeting the IGF Axis in Cancer: A Biomarker Assessment.

Front Oncol 2015 8;5:142. Epub 2015 Jul 8.

Department of Oncology, Mayo Clinic , Rochester, MN , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2015.00142DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4495315PMC
July 2015

Can we unlock the potential of IGF-1R inhibition in cancer therapy?

Cancer Treat Rev 2014 Oct 4;40(9):1096-105. Epub 2014 Aug 4.

Department of Oncology Laboratories, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, UK; Oxford Cancer Centre, Churchill Hospital, Oxford OX3 7LE, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2014.07.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196677PMC
October 2014

Patient-derived xenograft models in gynecologic malignancies.

Am Soc Clin Oncol Educ Book 2014 :e258-66

From The Walter and Eliza Hall Institute of Medical Research and Royal Women's Hospital, Parkville, Victoria, Australia; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre/University of Toronto, Toronto, Canada; Department of Oncology, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14694/EdBook_AM.2014.34.e258DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4156101PMC
November 2015

Tumorgrafts as in vivo surrogates for women with ovarian cancer.

Clin Cancer Res 2014 Mar 7;20(5):1288-97. Epub 2014 Jan 7.

Authors' Affiliations: Departments of Oncology, Radiation Oncology, and Molecular Pharmacology and Experimental Therapeutics; Department of Health Sciences Research, Division of Biomedical Statistics and Informatics; Division of Gynecologic Surgery; Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota; and Women's Cancer Program, Samuel Oschin Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-2611DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3947430PMC
March 2014

Patient-derived xenograft models to improve targeted therapy in epithelial ovarian cancer treatment.

Front Oncol 2013 Dec 4;3:295. Epub 2013 Dec 4.

The Kinghorn Cancer Centre, St Vincent's Clinical School, Garvan Institute of Medical Research , Sydney, NSW , Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2013.00295DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3849703PMC
December 2013

Dual HER/VEGF receptor targeting inhibits in vivo ovarian cancer tumor growth.

Mol Cancer Ther 2013 Dec 15;12(12):2909-16. Epub 2013 Oct 15.

Corresponding Author: Paul Haluska, Division of Medical Oncology, Mayo Clinic College of Medicine, 200 First St. SW, Rochester, MN 55905.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-13-0547DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880137PMC
December 2013

Two birds with one stone: octreotide treatment for acromegaly and breast cancer.

J Clin Oncol 2013 Aug 24;31(23):e398-400. Epub 2013 Jun 24.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1354, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.46.6383DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878051PMC
August 2013

A phase I trial of the IGF-1R antibody Cixutumumab in combination with temsirolimus in patients with metastatic breast cancer.

Breast Cancer Res Treat 2013 May 19;139(1):145-53. Epub 2013 Apr 19.

Section of Breast Oncology, Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, 660 South Euclid Avenue, P.O. Box 8056, St. Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-013-2528-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517667PMC
May 2013

Hormone response in ovarian cancer: time to reconsider as a clinical target?

Endocr Relat Cancer 2012 Dec 9;19(6):R255-79. Epub 2012 Nov 9.

Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-12-0175DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3696394PMC
December 2012

The insulin-like growth factor system in cancer.

Endocrinol Metab Clin North Am 2012 Jun;41(2):335-50, vi

Department of Oncology, Mayo Clinic College of Medicine, 200 First Street Southwest, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ecl.2012.04.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3614012PMC
June 2012

An organ system based approach to prognosis in advanced melanoma.

Front Biosci (Elite Ed) 2012 06 1;4:2723-33. Epub 2012 Jun 1.

Department of Medicine, Division of Hematology, Mayo Clinic Graduate School of Medicine, 200 First Street SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2741/e586DOI Listing
June 2012

Quantifying insulin receptor isoform expression in FFPE breast tumors.

Growth Horm IGF Res 2012 Jun-Aug;22(3-4):108-15. Epub 2012 Apr 30.

Department of Oncology, Mayo Clinic, Rochester, MN 55905, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ghir.2012.04.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3392524PMC
June 2013

An open-label study to describe pharmacokinetic parameters of erlotinib in patients with advanced solid tumors with adequate and moderately impaired hepatic function.

Cancer Chemother Pharmacol 2012 Mar 22;69(3):605-12. Epub 2011 Sep 22.

Department of Clinical Pharmacy, School of Pharmacy, University of Colorado Cancer Center, Mail Stop C238, 12850 East Montview Blvd., V20-1223, Aurora, CO, 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-011-1733-6DOI Listing
March 2012

Insulin-like growth factor pathway.

Authors:
Paul Haluska

J Thorac Oncol 2010 Dec;5(12 Suppl 6):S478-9

Department of Oncology, Mayo Clinic, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.JTO.0000391374.71505.a2DOI Listing
December 2010

Heat shock protein 90 inhibition depletes LATS1 and LATS2, two regulators of the mammalian hippo tumor suppressor pathway.

Cancer Res 2010 Nov 14;70(21):8642-50. Epub 2010 Sep 14.

Division of Oncology Research, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-10-1345DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2970685PMC
November 2010

Molecular markers for novel therapies in neuroendocrine (carcinoid) tumors.

Endocr Relat Cancer 2010 Sep 25;17(3):623-36. Epub 2010 Jun 25.

Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1677/ERC-09-0318DOI Listing
September 2010

Resistance pathways relevant to insulin-like growth factor-1 receptor-targeted therapy.

Curr Opin Investig Drugs 2009 Oct;10(10):1032-40

Mayo Clinic College of Medicine, Division of Medical Oncology, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
October 2009

Cixutumumab.

Expert Opin Investig Drugs 2009 Jul;18(7):1025-33

Mayo Clinic College of Medicine, Division of Medical Oncology, 200 First St. SW Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543780903055049DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939377PMC
July 2009

The pathway ahead in melanoma trials.

Oncology (Williston Park) 2009 May;23(6):496, 498, 500

Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
May 2009

IGF-1 receptor inhibitors in clinical trials--early lessons.

J Mammary Gland Biol Neoplasia 2008 Dec 21;13(4):471-83. Epub 2008 Nov 21.

Department of Oncology, Mayo Clinic, 200 First St. SW., Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10911-008-9104-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2728362PMC
December 2008